US sharemarkets rallied on Tuesday as the stabilisation in Chinese markets allowed investors to shift focus to US corporate earnings. Pfizer rose 2.7% after the drug maker beat expectations on a lift in vaccine sales.
Post Views: 306
US sharemarkets rallied on Tuesday as the stabilisation in Chinese markets allowed investors to shift focus to US corporate earnings. Pfizer rose 2.7% after the drug maker beat expectations on a lift in vaccine sales.